SO vs VOR · P/E 22, rev $29.55B vs $813.9M cap
Southern Company (SO) versus Vor Biopharma Inc (VOR) — a side-by-side from cached financials, not a winner call.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Vor Biopharma Inc (VOR) is a biotechnology company listed on NASDAQ.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
VOR does not have a complete income-statement cache yet.
SO currently screens at market cap $101.55B and trailing P/E 22.1. VOR currently screens at market cap $813.9M.
Not investment advice. Open the SO and VOR stock pages for the full models.
Not investment advice.